Stabilization of an E3 ligase-E2-ubiquitin complex increases cell surface MHC class I expression.

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Kaposi's sarcoma-associated herpesvirus (KSHV) encodes the K3 ubiquitin E3 ligase, which targets cell-surface MHC class I (MHC I) for degradation.
• K3 utilizes the E2 enzyme Ubc13 to form K63-linked polyubiquitin chains on MHC I, promoting clathrin-mediated endocytosis and lysosomal degradation.

Purpose of the Study:

• To identify mechanisms that regulate K3-mediated MHC I downregulation.
• To investigate the role of specific ubiquitin modifications in MHC I trafficking.

Main Methods:

• Utilized a ubiquitin isoleucine-44-alanine (I44A) mutant to probe K3 ligase activity.
• Observed the effects of the I44A mutant on MHC I ubiquitination and cell-surface expression.
• Visualized transient substrate-E3-E2-ubiquitin complex interactions in vivo.

Main Results:

• The I44A ubiquitin mutant specifically inhibited K3-mediated MHC I downregulation by preventing MHC I polyubiquitination.
• I44A stabilized the MHC I-K3-Ubc13-ubiquitin complex, enabling in vivo visualization of the interaction.
• Identified a potential substrate hierarchy for K3 activity across different MHC I alleles.
• Observed increased cell-surface MHC I in control cells treated with I44A, suggesting an endogenous ligase involved in MHC I regulation.

Conclusions:

• The I44A ubiquitin mutant serves as a valuable tool to study K3 ligase function and MHC I regulation.
• The findings suggest the existence of an endogenous E3 ligase that regulates cell-surface MHC I expression.
• This study provides a foundation for understanding viral manipulation of the immune system and host immune evasion strategies.